industrial sector

Hindalco industries ltd- we sold 200 shares of hindalco co. ltd. at rs.193.05
because it has recovered 4% so we sold these many shares to minimise the
losses.

RIL

We bought 500 RIL shares on 16.3.2011 at rs. 1046.45 because the company
was changing certain policies in the company and moreover the stocks to
price earning ratio was 17.39 and the dividend yield of the company was
0.67%..

Reliance Industries ltd- We sold 500 shares at rs. 1002.7 on 22.3.2011

because it has recovered 4-5% thereby minimizing the losses.

Havell's india ltd

We bought 500 shares of Havell's India Ltd on 17.3.2011 at rs.359.9 because

after havells acquired Sylvania ,it has strongly set its footprint in the lucrative
american and latin european markets.Expected turnaroud of Sylvania and
entry into newer segments in india will drive havells growth..

We sold 200 shares of Havells India ltd on 22.3.2011 at rs. 354.8 because the
profits were declining and was expected to fall more.

Automobile sector

Bajaj auto ltd

We bought 100 shares of Bajaj Auto Ltd. on 16.3.2011 at rs 1368.9 because

there was a growing opportunity in the market

We bought additional 100 shares at rs. 1364.95 because Bajaj Auto Ltd is
planning to launch new pulsar range in april 2011 and moreover, there is an
expected growth in two wheeler segment.

We sold 600 shares of BAL at rs. 1370 on 18.3.2011 because it wasnt

generating enough profits for the company.

Tata Motors ltd

We bought 250 shares at rs.1171.4 on 16.3.2011 because on 15.3.2011
intraday Tata Motors touched intraday high of 1159.95 and intraday low of
1128.65 and market opportunities were good.

Pharmaceutical sector

Sun pharmaceuticals industries ltd

We bought 100 shares at 431.25 on 15.3.2011 and 150 shares of Sun

Pharma at rs.433 on 18.3.2011 and additional 100 shares at 434.5 because
sunpahrma is buying all outstanding Caraco shares at USD 5.25/share in cash
CNBC-TV18 alert:
-Sun Pharma currently holds 75.8% in Caraco
-Sun Pharma had proposed to take Caraco Private at USD 4.75/sh in December
-Caraco CMP USD 5.12 + 9% on NYSE
We sold 100 shares at 434.75 on 18.3.2011 because it was not giving much profit but
there was an expectation of a rise in prices so we sold only 100 shares keeping rest for the
furthur increment.

Ranbaxy Laboratories ltd

we bought 250 shares at rs 470.1 on 18.3.2011 because Ranbaxy's core performance for
2QCY10 was better than what the company had expected.it expected core EPS of Rs
11.6 for CY11E (assuming some normalization of the core US business) and Rs 16.3 for
CY12 (assuming full recovery in the US). The estimates exclude MTM forex gains and
one-off upsides from Para-IV opportunities. Ranbaxy is currently valued at 30.7x CY11E
core EPS and 21.8x CY12E core EPS. Our current DCF value of all potential Para-IV
upsides is Rs 90 per share.
However, we could not sell the shares because we were waiting for the prices to rise as it
went in loss and didnt rise.